A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.
PHASE1
A new tablet form of PF-04531083 has been manufactured. Previously the comp...
To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications
PHASE1
The purpose of this study is to quantify the effect of multiple doses of PF...